Manufacturing

Roche is making a bold move in the field of allogeneic cell therapy with its recent acquisition of Poseida Therapeutics, a San Diego-based biotech firm. This $1 billion upfront deal underscores Roche's commitment to expanding its portfolio in cell and gene therapies, particularly targeting

Roche is making a bold move in the field of allogeneic cell therapy with its recent acquisition of Poseida Therapeutics, a San Diego-based biotech firm. This $1 billion upfront deal underscores Roche's commitment to expanding its portfolio in cell and gene therapies, particularly targeting

The Nanoimprint Lithography (NIL) system market is experiencing substantial growth propelled by its applications across multiple sectors such as semiconductor manufacturing, data storage, optics, and biotechnology. Valued for its characteristics of high resolution, scalability, and

In the modern, interconnected world, industries are inundated with enormous volumes of data. The challenge of transforming this data into actionable insights is critical for the efficiency and success of organizations globally. When data remains unprocessed or is improperly analyzed, it gives rise

Nanotechnology is revolutionizing the cosmetics industry, particularly in the realm of skin care. By leveraging the unique properties of nanoparticles, researchers are overcoming traditional challenges associated with the delivery and efficacy of antioxidants in skin care formulations. This article

The eligibility criteria for semaglutide, a medication that has seen rapidly expanded use beyond its initial approval for type 2 diabetes, reflect broader implications for healthcare policies and pharmaceutical budgets in the United States. Initially, semaglutide was approved by the US Food and